Alnylam Pharmaceuticals (ALNY) Change in Inventory (2018 - 2026)

Alnylam Pharmaceuticals (ALNY) has reported Change in Inventory for 9 consecutive years, with -$280000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory rose 97.49% year-over-year to -$280000.0; the trailing twelve-month figure through Jun 2026 stood at $11.9 million (up 149.43% YoY), and the FY2025 full-year result was -$8.5 million, up 37.65% from the prior year.
• Change in Inventory slipped to -$280000.0 in Q2 2026 per ALNY's latest filing, from $3.3 million in the prior quarter.
• Across five years, Change in Inventory topped out at $19.0 million in Q4 2022 and bottomed at -$12.0 million in Q4 2023.
• Historically, Change in Inventory has averaged -$180611.1 across 5 years, with a median of -$1.4 million in 2022.
• The widest YoY moves for Change in Inventory: up 1732.63% in 2025, down 28150.0% in 2025.
• Over 5 years, Change in Inventory stood at $19.0 million in 2022, then sank by 163.18% to -$12.0 million in 2023, then jumped by 92.92% to -$849000.0 in 2024, then surged by 1732.63% to $13.9 million in 2025, then tumbled by 102.02% to -$280000.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$280000.0, $3.3 million, and $13.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.